top of page
< Back

LiveLung & Cancer Services Host Biomarker Lunch & Learn

LiveLung & Cancer Services Host Biomarker Lunch & Learn

PRESS RELEASE
For Immediate Release

LiveLung & Cancer Services Host Biomarker Lunch & Learn

Winston-Salem, NC - May 2, 2024—LiveLung, in partnership with Cancer Services, is hosting Cancer Survivor Lunch, Learn & Live: The Role of Biomarkers in Treatment Decisions on Tuesday, 11:30am-1:30pm, May 21, 2024 at Graylyn Estate and Conference Center, Mews, 1900 Reynolda Road, Winston-Salem, NC. This event is free and open to cancer patients and their care partners in the Triad.
Keynote Speaker Jimmy Ruiz, MD, Atrium Wake-Forest Professor of Medicine in the Section of Hematology and Oncology will present on biomarkers and will take questions following his presentation. The Lunch and Learn will also feature a panel discussion featuring breast cancer, rare cancer, and lung cancer patients with certain biomarkers. The panel, moderated by cancer survivor and LiveLung founder Dusty Donaldson, will also include a care partner. Panelists include Melanie Sisk, Elizabeth Speight, CRNA, and Kevin Speight, MD, and others.
Dr. Ruiz, who specializes in lung cancer, serves as the assistant director for clinical research at Atrium Health Wake Forest Baptist Comprehensive Cancer Center and professor of medicine at Wake Forest University School of Medicine. Dr. Ruiz received his medical degree at Southern Illinois University and completed residency in internal medicine and a fellowship in hematology and oncology at Atrium Health Wake Forest Baptist. His clinical research focuses on promoting clinical trial activation and participation, especially among individuals from diverse communities of color. Dr. Ruiz is past president of the North Carolina Oncology Association and an active member of the Alliance for Clinical Trials in Oncology, the American Society of Clinical Oncology, and the National Hispanic Medical Association.
Cancer patients and care partners are welcome to register for this free event to learn about the importance of biomarkers in cancer treatment here:
https://livelung.org/event/biomarker-lunch-learn/.
LiveLung is a 501(c)(3) nonprofit organization on a mission to improve health outcomes by advancing lung cancer education, early detection, and compassion for people impacted by lung cancer. We do this by hosting a network of monthly educational community lung cancer patient groups. We provide resource bags to dozens of cancer centers where nurse navigators give them to newly diagnosed lung cancer patients.
This program is made possible by generous support from Lilly and Foundation Medicine.

bottom of page